Republic Bancorp RBCAA Rallies 099 as Bulls Target 8045 20260514 Markets Raise Chances for a Fed Rate Hike Following Hot Inflation Report Saratoga SAZ Q1 2026 Earnings Miss by Significant Key Takeaways UWM UWMC Crushes Q1 2026 Estimates EPS 008 Tops Views AI Capital Spending Boom Echoes Historic Peaks as Raymond James Warns of Potential Bust WSJs Heard on the Street Writers Reveal Eighth Annual StockPicking Contest Selections Oil Prices Decline as USIran Peace Deal Hopes Rise Strait of Hormuz Reopening Possible Oura Files Confidentially for IPO Smart Ring Maker Seeks Public Listing Morgan Stanley Adjusts Walmart Forecast Amid Persistent Inflation Pressures Precious Metals Retreat Gold and Silver Prices Decline Amid Market Uncertainty RAND Q1 2026 Earnings Reported EPS of 018 Stock Falls 313 SPIR Q1 2026 Earnings Earnings Miss Meets Positive Stock Reaction Amid Strategic Shifts VIR Q1 2026 Earnings Significant EPS Miss as Biotech Continues Investment Phase SES AI Q1 2026 Earnings EPS Misses Estimates as Company Continues RD Focus COPEL Q2 2025 Earnings Strong EPS Beat of 5848 Despite Marginal Stock Decline ANVS Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist Anixa Biosciences ANIX Slides 215 as Biotech Sector Headwinds Return Shoals Technologies SHLS Edges Higher Testing Key Support Levels Fox Factory FOXF Jumps 264 as Shares Approach Key Resistance Level Fluor Corporation FLR Rallies 383 Key Levels and Market Sentiment Sylvamo Corporation SLVM Holds Steady Near Support as Trading Volume Modulates Chinese Investors Flock to Dividend Stocks Amid Market Uncertainty Shein Acquires Everlane Can the Fast Fashion Giant Reshape Ethical Luxury Enbridge Receives Higher Price Target as Cash Flow Outlook Remains Strong Fiserv Partners with OpenAI to Bring Frontier AI to Banking Platforms Malaysian Food StartUp Targets Commercialization of LabGrown Unagi Meta Plans 6065 Billion Capital Spending Surge for AI Massive Data Center SBAC Q1 2026 Earnings EPS Misses Estimates Amid Tower Leasing Headwinds Monopar Therapeutics MNPR Slips Slightly While Holding Key Technical Levels